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Summary 
Bioactive glasses are able to bond to bone through formation of carbonated hydroxyapatite in body fluids, and fluoride-
releasing bioactive glasses are of interest for both orthopaedic and in particular dental applications for caries inhibition. 
Melt-derived glasses in the system SiO2-P2O5-CaO-Na2O with increasing amounts of CaF2 were prepared by keeping 
network connectivity and the ratio of all other components constant.  
pH change, ion release and apatite formation during immersion of glass powder in simulated body fluid at 37°C over up 
to two weeks were investigated. Crystal phases formed in SBF were characterised using infra-red spectroscopy, X-ray 
diffraction with Rietveld analysis and solid-state nuclear magnetic resonance spectroscopy (19F and 31P MAS-NMR). 
Results show that incorporation of fluoride resulted in a reduced pH rise in aqueous solutions compared to fluoride-free 
glasses and in formation of fluorapatite (FAp), which is more chemically stable than hydroxyapatite or carbonated 
hydroxyapatite and therefore is of interest for dental applications. However, for increasing fluoride content in the glass, 
fluorite (CaF2) was formed at the expense of FAp. Apatite formation could be favoured by increasing the phosphate 
content in the glass, as the release of additional phosphate into the SBF would affect supersaturation in the solution and 
possibly favour formation of apatite.  
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Introduction 
"Bioactive glass" is a generic term for a group of silicate glasses which have a highly disrupted structure (consisting of 
Q2 silica chains with a large number of non-bridging oxygens – two per silicon tetrahedron), which degrade in aqueous 
solution and release ions such as calcium. These glasses are also known to form carbonated hydroxyapatite (HCA) in 
vitro in simulated body fluids (SBF), which have ionic concentrations close to human blood plasma [1], and this HCA 
layer is generally thought to facilitate attachment of proteins such as collagen, fibronectin and vitronectin which 
osteoblasts bind to and proliferate [2], thereby allowing for the formation of an intimate bond to bone [3].  
Bioactive silicate glasses are of interest for use as bone grafts, implant coatings, in aluminium-free glass polyalkenoate 
(ionomer) bone cements [4] and even in dentifrices [5], and in all these applications addition of fluoride would be 
beneficial. Fluoride is well known to prevent dental cavities by inhibiting enamel and dentine demineralisation, 
enhancing remineralisation and inhibiting bacterial enzymes [6,7]. An important factor here is the formation of 
fluorapatite (FAp), which is more acid resistant than HCA, the main component of enamel and dentine.  
The ability of bioactive glasses to form apatite in body fluids is also used in toothpaste for treating dentine 
hypersensitivity [5]. Dentine hypersensitivity is caused by dentinal tubules of root dentine being exposed. The 
toothpaste contains bioactive glass with a large fraction of particles small enough to enter the dentinal tubules. 
Formation of apatite then occludes the tubules and thus reduces sensitivity. Formation of FAp rather than HCA would 
be beneficial, as it is more chemically stable and would therefore less readily dissolve when the mouth is exposed to 
acidic conditions.  
Fluoride is also known to increase bone density [Lit: ADA report + ref. 9], and despite a narrow therapeutic window 
and some dispute on effectiveness in prevention of fractures [8,9] fluoride-releasing implants might be of interest for 
patients suffering from osteoporosis. 
We recently characterised the structure of a series of glasses in the system SiO2–P2O5–CaO–Na2O with increasing 
concentrations of CaF2 [10]. Network connectivity (NC) [11] was fixed at 2.13 by adding CaF2 while the ratio of all 
other components was kept constant, assuming that fluoride stays associated with calcium, i.e. no Si-F bonds are formed 
[10,12]. Our hypothesis was that by keeping NC fixed we would not affect the degradability of the glasses and their 
ability to form apatite in SBF in vitro. We therefore performed degradation experiments in SBF and demonstrate the 
effects of glass composition and structure have on degradation, in vitro apatite formation and pH of fluoride-containing 
bioactive glasses. To our knowledge this is the first characterisation of apatite formed by bioactive glasses in simulated 
body fluid using 19F and 31P solid-state nuclear magnetic resonance.  
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Materials and methods 
Glass synthesis 
Glasses in the system SiO2–P2O5–CaO–Na2O were prepared using a melt–quench route. CaF2 was added in increasing 
amounts while network connectivity (NC) and the ratio of all other components were kept constant (glasses A to G, 
Table 1). In addition, one sodium-free glass was synthesised (glass H, Table 1). Mixtures of analytical grade SiO2 
(Prince Minerals Ltd., UK), P2O5, CaCO3, Na2CO3 and CaF2 (all Sigma-Aldrich) were melted in a platinum-rhodium 
crucible for 1 h at 1430°C in an electric furnace (Lenton EHF 17/3). A batch size of approximately 100 g was used. 
After melting, the glasses were rapidly quenched into water to prevent crystallisation. After drying, the glass was 
ground using a vibratory mill (Glen Creston Gy-Ro mill) for 7 min and sieved to a particle size below 38 µm. All 
compositions were obtained in an amorphous state as confirmed by powder X-ray diffraction experiments (XRD; results 
not shown).  
pH and ion release in simulated body fluid (SBF) 
Simulated body fluid was prepared using 7.996 g sodium chloride, 0.350 g NaHCO3, 0.224 g potassium chloride, 
0.228 g K2HPO3 x 3H2O, 0.305 g MgCl2 x 6H2O, 0.368 g CaCl2 x 2H2O, 0.071 g sodium sulfate, and 6.057 g 
tris(hydroxymethyl)amino methane, (CH2OH)3CNH2, (Tris) per litre SBF, and pH was adjusted using 1 N hydrochloric 
acid (all chemicals Sigma-Aldrich) as described by Kokubo et al. [13]. SBF was kept at 37°C.  
100 mL SBF were pipetted into 150 mL PE bottles. pH was measured using a pH meter (Oakton Instruments, NL) and 
150 mg of glass powder (< 38 µm) were dispersed in the SBF, corresponding to a concentration of 1.5 g/L. Samples 
were placed in an orbital shaker at 37°C at an agitation rate of 60 rpm for 3 days, 1 week and 2 weeks. SBF from the 
same batch without glass powder was used as control. After removing the samples from the shaker pH was measured 
and solutions were filtered through medium porosity filter paper (5 µm particle retention, VWR International). Filter 
paper was dried at 37°C and the solutions were filtered sterile (0.2 µm cellulose acetate syringe filters, Anachem, UK) 
and kept at 4°C.  
Undiluted solutions (for analysis of phosphorus) as well as samples diluted by a factor 1:200 (for sodium, results not 
shown) and 1:10 (for analysis of silicon, calcium, magnesium and potassium; results for magnesium and potassium not 
shown) were quantitatively analysed by inductively coupled plasma (ICP) emission spectroscopy (iCAP 6000, Thermo 
Scientific).  
Fluoride-release into SBF was measured using a fluoride-selective electrode (Orion 9609BNWP with Orion pH/ISE 
meter 710, both Thermo Scientific). Calibration was performed using standard solutions prepared using SBF to account 
for ionic strength.  
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Characterisation of glass powders 
Dried powders were analysed using Fourier-transform infrared spectroscopy (FTIR, Perkin-Elmer Spectrum GX, data 
collected from 1600 to 500 cm-1) and XRD (Phillips PW1700, 40 kV/40 mA, CuK, data collected at room temperature 
with a 0.04°2 step and a count rate of 4 s per step, from 2 values of 10° to 60°). For Rietveld analysis, Philips PC RD 
XRD files were converted to GSAS raw files using ConvX software. Rietveld analyses were performed using GSAS 
and EXPGUI software [14].  
Structure was analysed using 19F and 31P magic angle spinning nuclear magnetic resonance (MAS-NMR). Experiments 
were performed using Bruker 200 MHz (4.7 T) and 600 MHz (14.1 T) spectrometers. 19F NMR data were collected at a 
Larmor frequency of 188.2 MHz under spinning conditions of 12.5 kHz in a 4 mm rotor. To avoid ringing effects from 
the probe, the Hahn-echo pulse sequence /2 was applied with a /2 pulse of 2.35 µs and the echo delay  of 
40 µs. A recycle delay of 10 s was used, with 16 dummy scans performed before counting. A 19F NMR background 
signal thoroughly acquired on the fluorine-free glass of this series was subtracted from the spectra of the fluorine-
containing glasses. 19F chemical shift scale was referenced using the -120 ppm peak of 1 M NaF aqueous solution as a 
secondary reference against CFCl3. 
31P MAS-NMR spectra on glasses were acquired at 81.0 MHz in a 4 mm rotor 
spinning at 4.5 kHz. 64 transients of a single pulse experiment with 2.5 µs /2 pulse and 49 s recycle delay were 
collected for each sample. 31P MAS-NMR spectra on glass powders after soaking in SBF were collected at 242.9 MHz 
in a 4 mm rotor spinning at 6 to 7 kHz with a 30 s recycle delay and 8 scans before counting. 31P chemical shift was 
referenced to 85% H3PO4. 
19F MAS-NMR spectra were fitted using dmfit software [15].  
Results and Discussion 
It is generally accepted that the formation of an apatite layer in body fluids facilitates attachment of osteoblasts (via 
proteins) on bioactive glasses (both in vitro and in vivo) and thereby enables bonding to bone [3]. While it is doubtful 
that the results of in vitro dipping tests in SBF can actually predict the behaviour of a material either during cell tests or 
in vivo and has in fact produced false positive and false negative results [16], degradation experiments of bioactive 
glasses in SBF can give us insight into glass dissolution, pH changes and apatite formation in buffered solutions with 
ionic concentrations similar to those in human blood plasma. In addition, formation of apatite is of interest for dental 
applications.  
We were particularly interested to see how glass composition, fluoride content and glass structure affect pH and apatite 
formation, as this information would enable us to design fluoride-containing bioactive glasses for specific applications. 
It is important to note that the glass system presented here is a model system which was not designed to give specific 
properties (e.g. high bioactivity) but was solely designed to help us understand the structure/property relationship in this 
type of biomaterials.  
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Effect of fluoride content on pH of SBF 
Soda-lime phosphosilicate-based bioactive glasses are well known to cause a pH rise upon immersion in aqueous 
solutions which favours apatite deposition in SBF but can negatively affect the surrounding tissue in vivo. The fluoride-
releasing glasses in this work clearly showed a pH rise during the first three days of immersion in SBF from about 7.27 
(the initial pH of the SBF) to up to over 8 (Fig. 1). After this initial pH increase the pH stayed constant over the 
remaining two weeks of the experiment. The pH rise, however, was less pronounced for increasing fluoride content in 
the glass (Fig. 2), as fluoride-free glass A gave a pH of 8.03 at one week while glass G, which has the highest CaF2 
content (33 mol%), gave a pH of 7.83. Sodium-free glass H gave a pH of 7.95 at one week (not shown).  
The effect of the fluoride content of the glass on the pH in aqueous solution can be explained by ion exchange processes 
on the glass surface. Cations such as Na+ or Ca2+ near the glass surface can go into solution in exchange for H+ ions 
from the solution (from dissociation of water into H+ and OH-), which results in a pH increase. Similarly, F- ions can be 
exchanged for OH- ions, removing hydroxyl ions from solution and providing fluoride ions which buffer the effect of 
alkali ion release; so that for increasing fluoride content in the glass the pH rise is less pronounced. 
Apatite deposition in SBF 
mention overlapping XRD pattern of HAp, FAp or HCA, give numbers of patterns!  
As the formation of apatite in SBF is strongly pH dependent [17], and the pH rise in SBF is less pronounced with 
increasing fluoride content in the glass, it might therefore be expected that the deposition of apatite in SBF decreases 
with increasing fluoride content in the glass. However, fluoride might be incorporated into the apatite to form 
fluorapatite, and as fluoroapatite has a much lower solubility than HCA and is stable at a lower pH, this might 
counterbalance the pH changes. We therefore followed the formation of apatite using FTIR, XRD and solid-state NMR.  
FTIR spectra of all glass compositions showed significant changes after immersion in SBF for 3 days and longer in 
comparison to the spectrum of the unreacted glass (shown in Fig. 3a for glass B). The bands for the untreated glass 
powder were mostly due to Si-O vibrational modes: Si-O stretch, Si-O alkali stretch and Si-O bend [18]: After 
immersion in SBF all spectra showed the following changes (Figs. 3a and 4a): disappearance of the NBO (non-bridging 
oxygens, Si-O- alkali+) band at 920 cm-1 and sharpening of the Si-O-Si stretch band at about 1030 cm-1. At the same 
time, new bands appeared at about 790 cm-1, which we assigned to Si-O-Si bond vibration between two adjacent SiO4 
tetrahedra. These changes indicate formation of a silica-gel surface layer after leaching of Ca2+ and Na+ ions and 
formation of Si-OH. Spectra after SBF immersion showed either a single peak or a split peak at approximately 
560 cm-1. This is the most characteristic region for apatite and other phosphates, and it corresponds to P-O bonding 
vibrations in a PO4
3- tetrahedron and indicates presence of crystalline calcium phosphates including HAp and HCA 
[18]. A single peak in this region suggests presence of non-apatitic or amorphous calcium phosphate (ACP) which is 
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usually taken as indication of presence of precursors to hydroxyapatite (HAp) [19]. Apatitic PO4
3- groups give 
characteristic split bands at 560 and 600 cm-1 [20], with a third signal at 575 cm-1 [21] observed for crystallites of small 
size. At one week (Fig. 4a), this split phosphate peak is most clearly pronounced for fluoride-free glass A, it is not 
present for glass B, and from glass C to G it gets more pronounced with increasing fluoride content. This suggests that 
small additions of fluoride affect apatite formation in SBF.  
Presence of carbonate substitution in the apatite is indicated by the peak at about 870 cm-1 present in glasses A and C to 
H after 1 week immersion in SBF (Fig. 4a) and in glass B after 2 weeks in SBF (Fig. 3a). In SBF treated glass, this 
carbonate peak is usually taken as an indication for carbonate being incorporated into the apatite, resulting in HCA 
rather than stoichiometric HAp [17]. It is difficult to distinguish whether this band is split, in which case it would be B-
type substitution (i.e. replacing a phosphate group). However, for most of the compositions treated in SBF for 1 week 
(Fig. 4a) and 2 weeks (3a) broad CO3
2- bands are present in the region starting from 1410 cm-1 which indicates B-type 
substitution. The CO3
2- signal for A-type substitution would be shifted to higher wavenumbers, starting from 1460 cm-1. 
The carbonates peaks are absent in glass B after 1 week in SBF (Figs. 3a and 4a) which is consistent with the absence of 
apatitic PO4
3- bands [17,20].  
Spectra also showed a shoulder at 1080 to 1090 cm-1 which corresponds to a P-O stretch which is also observed in B-
type substituted HCA [20]. At 1 week, it is most clearly pronounced in glasses A and high fluorine-content glasses (Fig. 
4a), while in glass B it becomes more pronounced at 2 weeks (Fig. 3a).  
Fig. 3b shows XRD patterns of glass B before SBF treatment and at three days, one week and two weeks of SBF 
immersion. At three days small peaks at 26, 28, 32, 33, 47, 50 and 52 2 (JCPDS 9-432) indicate presence of apatite; 
these peaks are superimposed on an amorphous halo. The position of this amorphous halo has shifted compared to the 
unreacted glass, due to formation of an ion-depleted silica-gel layer. The apatite peaks at one week are less pronounced 
than at three days due to a lower initial pH of the SBF (7.24 instead of 7.27), which suggests that formation of apatite 
for this glass composition is very susceptible to slight pH changes. At two weeks, peaks become clearly pronounced and 
additional reflections become visible; however, the lines remain very broad which indicates small size and highly 
disordered character of the crystals. This is typical for apatites precipitated from glass soaked in SBF [22]. Clear 
appearance of apatite Bragg's reflections after 2 weeks is consistent with presence of characteristic apatitic features on 
FTIR spectra of this glass (Fig. 3a).  
Fig. 4b shows that at one week all glasses (except B) clearly show presence of apatite by XRD. However, for increasing 
fluoride content peaks of fluorite (CaF2) at 28, 47 and 56 2 dominate the XRD pattern. Spectra were fitted using 
Rietveld analysis (Fig. 5a); plotting the results for relative amounts of crystal phases (Fig. 5b) shows sigmoidal curves 
of increasing relative amounts of fluorite with increasing CaF2 content in the glass, while the relative amount of apatite 
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decreases. This can be explained by the fact that the glasses in this series have low phosphate contents (1.07 mol% or 
less) which favours formation of CaF2 rather than apatite, as we have an excess of calcium and fluoride ions, but not 
enough phosphate [22]. Crystallite size analysis using the Scherrer equation gave crystallite sizes between 4 and 20 nm. 
However, this only considers line broadening due to particle size reduction, while partial substitutions and resulting 
variations in lattice parameters will also broaden the lines and thereby affect crystallite size calculations. Crystallite size 
analysis of apatite formed on bioactive glasses in SBF previously showed crystal sizes in the range of 16 to 26 nm [22], 
and crystallites in our study are also likely to be in the nanometer size range (below 50 nm).  
SBF-treated glass powders were analysed using 31P and 19F MAS-NMR, and Fig. 6 shows 31P MAS-NMR results for 
untreated glass powder and for glass powder after immersion in SBF. Both before and after SBF treatment phosphate is 
present as orthophosphate. In the untreated glass the chemical shift of the orthophosphate peak moved from 9 ppm 
(glass A) to 3 ppm (glass H) with increasing CaF2 content in the glass (Fig. 6c) which we explained by changes in the 
Ca/Na ratio charge balancing orthophosphate [10]. After SBF treatment of two weeks, however, we see broad signals 
with a chemical shift of around 3 ppm for all glass compositions (Fig. 6a). The average width of the line at 3 ppm, 
730 Hz, is much broader than in crystalline apatite, about 120 Hz. This broadening of the 31P MAS NMR signal for 
precipitated nanocrystalline apatite was studied by Jäger et al. [23]. This study reveals that the broadening is due to a 
disordered phase of calcium phosphates that covers the core of apatite nanocrystals. This disordered phase is often 
regarded as an apatite precursor. However, in our case for glasses after SBF treatment carbonate substitution is clearly 
detected from FTIR, and this carbonate substitution together with probable fluorine incorporation are additional line 
broadening factors for 31P MAS NMR spectra.  
Additionally, the 31P NMR peaks in Fig. 6a are asymmetric, which is particularly pronounced for F-free glass A. We 
estimated by deconvolution [15] that this asymmetry is due to a broad signal at 5-6 ppm for compositions A, C, D and 
H, with glass A showing the highest relative amount (~15%) of this additional phase. This additional feature is different 
from the initial glass signal and is also observed for sodium-free glass H. We assume that it could arise from mixed 
calcium sodium phosphates, presumably amorphous, absorbed on the glass surface while soaking in SBF. The 
asymmetry largely disappears in the highest F containing glass G and the signal is broader compared to the other 
compositions in Fig. 6a after 2 weeks in SBF. The width of the 31P NMR line for glass G after 3 days in SBF (Fig. 6b) 
was even broader than for the same glass after 2 weeks due to presence of the residual glass signal at around 6ppm. This 
implies that phosphates both from the glass and from SBF take part in the process of apatite formation in these glasses.  
To clarify whether fluoride contents in the glass result in formation of FAp in addition to/rather than HCA (as the XRD 
pattern overlap and we therefore cannot distinguish between these two phases by using XRD alone), 19F MAS NMR 
was run on SBF-treated glasses. Fig. 7 shows 19F MAS-NMR spectra for both untreated glass and glass powder after 
immersion in SBF for 2 weeks (Fig. 7a) and 3 days (Fig. 7b). Apart from the sodium-free glass (H) all compositions 
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showed presence of mixed sodium calcium fluoride species in the untreated glass [10]. The sodium-free glass (H) gives 
a single peak at -89 ppm corresponding to F-Ca(n) species (Fig. 7b).  
After SBF treatment all glasses show a new feature between -101 ppm and -107 ppm and a broad shoulder on the low 
frequency side (right hand side) of the spectra. The main feature becomes more prominent after 2 weeks, and the broad 
low frequency shoulder decreases in intensity. This signal between -101 ppm to -107 ppm we assigned as an overlap 
between fluorapatite and fluorite. The fraction of the latter increases in the glasses with high CaF2 content, leading to a 
more negative overall shift. This is in agreement with the results of Rietveld analysis. The broad signal at about 
-140 ppm to -150 ppm can arise from mixed Ca/Na fluorine complexes adsorbed on the glass powder. This could be due 
to interaction of cations from the SBF solution, in particular sodium, with fluoride ions released from the glass during 
its dissolution. The proportion of this species decreases with time due to consumption of fluorine for formation of 
fluorapatite and fluorite. Additionally, the low frequency broad feature, for instance in glass C, could be partially caused 
by the residual glass phase. As an alternative explanation for the signal in this region we do not exclude presence of 
Si-F linkages resulting from adsorption of fluoride ions to the silca-gel surface layer. 
Glass dissolution and ion release in SBF 
Experimental concentration of phosphorus in SBF was (21.6  0.1) mg/L (theoretical: 30.9 mg/L) and of calcium was 
(84.1  1.4) mg/L (theoretical: 100.3 mg/L). These differences might be caused by precipitation of apatite in SBF 
without added glass powder, although no precipitate was visible. Alternatively, hydration of chemicals during storage 
used for preparation of SBF could have resulted in lower actual concentrations in the solution.  
Fig. 8 shows ionic concentrations in SBF after immersion of glass powder for 1 week. For all glass composition, the 
phosphate concentration drops sharply compared to SBF (Fig. 8a). This is caused by formation of apatite (the Ca-P 
phase has started to form by 3 days according to XRD and FTIR): The glasses in this series have low phosphate 
contents, so phosphate ions from the SBF are used during formation of apatite. The considerable differences in 
phosphate concentrations between glass compositions can be explained by differences in formation of apatite. Glasses 
which formed apatite most readily (A, F to H) give the lowest phosphate concentration in SBF. Glass B, on the other 
hand, which showed no split FTIR phosphate peak and had the lowest XRD peak intensity at one week in SBF, gives 
the highest phosphate concentration in SBF.  
At one week, Si has reached the solubility limit (around 60 mg/L with SiO2 having a solubility of 0.12g/L in water) for 
all glasses (Fig. 8b). When silicon reaches the solubility limit, the phosphate concentration drops, and apatite is formed 
as formation of a silica gel layer is thought to aid nucleation of apatite. Calcium concentration in SBF decreases with 
increasing CaF2 content from glass B to G (Fig. 8c), which can be explained by calcium ions being used up during 
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formation of apatite and fluorite. Sodium-free glass H gives the highest calcium concentration in SBF, which is due to a 
higher calcium content in the glass.  
Fig. 8d shows that fluoride release does not increase with increasing fluoride content in the glass: Fluoride 
concentration in SBF was higher for glass C than for B (due to a higher CaF2 content in the glass) but decreased from 
glass C to H. Again, this can be explained by formation of FAp and fluorite. As both FAp and fluorite have a very low 
solubility in water, fluoride release decreases despite a higher fluoride concentration in the glass.  
For dental applications, it is often implied that an increase in fluoride release from dental materials is better for caries 
prevention and formation of fluorapatite. However, our results show that high fluoride release might result in formation 
of fluorite rather than fluorapatite, but can also have negative effects such as a local drop in pH. Rather than increasing 
the fluoride-content in a ceramic material, it is important to a) design a composition which forms FAp rather than 
fluorite while releasing fluoride and b) to analyse the products formed in SBF in detail.  
Fluoride-containing bioactive glasses in the literature 
Bioactive glasses and ceramics are used as biomaterials for the repair of bone tissue, and fluoride-releasing bioactive 
glasses are of interest in both orthopaedic and dental applications due to their ability to form fluorapatite in body fluids. 
A number of publications investigate the ability of fluoride-containing bioactive glasses to form apatite in SBF [18,24-
26]. Fujii et al. [24] tested fluoride-containing bioactive glasses in SBF and performed XRD on the SBF-treated 
samples. They assigned the XRD peak at 28°2 HAp; however, the XRD patterns show that its intensity is enhanced. 
The main peaks to be expected for fluorapatite (JCPDS 15-876) are 31.9 (100% relative intensity), 33.1 (60%), 32.3 
(55%) and 25.9 (40%). The peaks at 28.2 and 29.1°2 only have relative intensities of 14 and 18%, respectively. Unless 
the structure shows orientation, we expect the experimental intensities in XRD to match the theoretical ones. The large 
peak at 28°2 might therefore be caused by overlapping peaks of apatite and fluorite, which suggests that fluorite is 
formed as well as apatite. Similar trends can be seen by fluoride-containing 45S5-based bioactive glasses by Hench et 
al. [25]. This suggests that fluoride-release from bioactive glasses often results in formation of fluorite in addition to 
FAp or HAp but presence of fluorite will remain undetected if SBF-treated samples are only analysed using FTIR (as is 
done in many publications, e.g. by Kim et al. [18]), or if XRD patterns are only recorded for 2 values of 40° or less 
(thereby missing the fluorite peaks at 47 and 56°2).  
Lusvardi et al., on the other hand, did not find formation of fluorite (CaF2) during SBF treatment, but their glasses 
formed calcite (CaCO3) in SBF before forming apatite. The authors explain this by absence of a silica-gel layer in their 
glasses during SBF treatment, which is often considered to activate apatite nucleation, so that while formation of apatite 
is thermodynamically favoured, apatite formation is retarded resulting in formation of calcite due to kinetic effects [26]. 
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However, the authors used Dulbecco’s modified Eagle’s medium (DMEM) with a HCO3
- concentration ten times higher 
than that of SBF according to Kokubo [13], and this could favour formation of calcite rather than apatite or fluorite.  
Often changes in glass behaviour (reactivity, degradation, pH or apatite formation) upon CaF2 addition are attributed to 
the effect of fluoride [24-26], while in fact they can be explained by changes in the glass network (network 
connectivity) due to unsuitable glass design: if CaF2 is substituted for network modifier oxides such as CaO or Na2O, it 
causes cross-linking of the silicate-network and an increased NC as shown previously in structural investigations [10] 
and molecular dynamics simulations [12]. As glass reactivity, degradation and apatite formation in bioactive glasses are 
highly susceptible to glass structure and NC, such glass design will make it difficult to determine if the changes are due 
to fluoride addition or due to changes in NC. We therefore added CaF2 by the ratio of network former to network 
modifier (and thus the network connectivity) constant. 
The results by Lusvardi et al. [26] show that all glasses in their series (up to 15 mol% CaF2) form apatite according to 
XRD within 15 days in SBF solution. However, due to their glass design (CaF2 added in exchange for CaO and Na2O, 
respectively) NC values for glasses containing 10 mol% CaF2 or above are  2.55. If we take the value of a NC = 2.4 as 
the cut off for bioactivity [11], we do not expect these glasses to form apatite in body fluids. NC values of above 2.4 
describe a glass with 40% Q3 species, which is a highly polymerised network that does not degrade easily in aqueous 
solutions and thus are not expected to form apatite. On the other hand it was shown that the phosphate phase of the glass 
structure has a huge impact on bioactivity of the glasses [22], as phosphate is present in an orthophosphate phase and 
does not form part of the actual silicate-network [10]. And an increase in phosphate content was shown to drastically 
increase bioactivity while limiting the pH rise in aqueous solutions [22]. We therefore conclude that the glasses by 
Lusvardi et al. [26] show bioactivity despite high network connectivity due to an increased phosphate content. This 
suggests that increasing the phosphate content in our glass system could increase the ability of the glasses to form 
apatite in physiological solutions.  
Conclusions 
Our results show that addition of fluoride results in formation of fluorapatite in simulated body fluid which is more acid 
resistant than carbonated hydroxyapatite and therefore fluoride-containing bioactive glasses are particularly interesting 
for applications in dentistry. However, our results show that high fluoride-content glasses in our system mainly form 
fluorite (CaF2) in SBF, and formation of apatite is reduced compared to the fluoride-free composition. This could be 
overcome by increasing the amount of phosphate in the glasses, as the release of phosphate would affect the 
supersaturation in SBF and thereby favour apatite deposition.  
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Tables 
 
Table 1:  Synthetic glass composition in mol% and theoretical network connectivity (NC).  
Glass SiO2 P2O5 CaO Na2O CaF2  NC 
A 49.47 1.07 23.08 26.38 -  2.13 
B 47.12 1.02 21.98 25.13 4.75  2.13 
C 44.88 0.97 20.94 23.93 9.28  2.13 
D 42.73 0.92 19.94 22.79 13.62  2.13 
E 40.68 0.88 18.98 21.69 17.76  2.13 
F 36.83 0.80 17.18 19.64 25.54  2.13 
G 33.29 0.72 15.53 17.75 32.71  2.13 
H 44.88 0.97 44.87 - 9.28  2.13 
        
 
 
Table 2:  Synthetic glass composition in mol%, theoretical network connectivity (NC) and experimental bioactivity 
(in terms of formation of an apatite layer in simulated body fluid) of glasses by Lusvardi et al. [12,26]  
Glass SiO2 P2O5 CaO Na2O CaF2  NC 
H 46.2 2.6 26.9 24.3 -  2.12 
HNaCaF2 5% 46.2 2.6 26.9 19.3 5.0  2.34 
HNaCaF2 10% 46.2 2.6 26.9 14.3 10.0  2.55 
HNaCaF2 15% 46.2 2.6 26.9 9.3 15.0  2.77 
HCaCaF2 5% 46.2 2.6 21.9 24.3 5.0  2.34 
HCaCaF2 10% 46.2 2.6 16.9 24.3 10.0  2.55 
HCaCaF2 15% 46.2 2.6 11.9 24.3 15.0  2.77 
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Figure captions 
Figure 1. pH in SBF over two weeks of immersion of glass powder for glasses with increasing fluoride content (A to 
G). (Error is about ± 0.03. Lines are drawn as a guide to the eye.) 
Figure 2. pH of SBF vs. CaF2 content in the glass at 1 week immersion of glass powder for glasses with increasing 
fluoride content (A to G).  
Figure 3. (a) FTIR spectra and (b) XRD patterns of untreated glass B (bottom) and after immersion in SBF for 3 days, 1 
week and 2 weeks. Crystal phase in XRD pattern is apatite ().  
Figure 4. (a) FTIR spectra and (b) XRD patterns of glasses with increasing fluoride content (glasses A to G) and 
sodium-free glass H at 1 week immersion in SBF. Crystal phase in XRD pattern are calcium fluoride (+) and 
apatite (). 
Figure 5. (a) Rietveld fitting of glass D at two weeks in SBF and (b) relative amount of crystal phases at 2 weeks in 
SBF according to Rietveld analysis vs. CaF2 content in the glass at 2 weeks immersion in SBF for glasses 
with increasing fluoride content (A to G). (Lines are drawn as a guide to the eye.)  
Figure 6. 31P MAS-NMR spectra of glasses (a) after 2 weeks in SBF, (b) after 3 days (shown for glass G only) and (c) 
before SBF treatment. Spinning side bands are marked by an asterisk.  
Figure 7. 19F MAS-NMR spectra of glasses (a) after 2 weeks in SBF, (b) after 3 days in SBF and (c) without SBF 
treatment. Approximate position of spinning side bands of 12.5 kHz spinning speed are marked by an 
asterisk.  
Figure 8. Concentrations of (a) phosphorus, (b) silicon, (c) calcium and (d) fluoride in SBF at 1 week immersion of 
glass powder for glasses with increasing fluoride content (A to G), a sodium-free glass (H) and SBF without 
addition of glass powder as control. 
 
 
